Skip Nav Destination
Issues
Neurodegenerative Diseases 2010, Vol. 7, No. 1-3
Effect of Heparin on APP Metabolism and Aβ Production in Cortical Neurons
Neurodegener Dis (2010) 7 (1-3): 187–189.
https://doi.org/10.1159/000295661
Cholesterol and Cognitive Performance in Normal Controls and the Influence of Elective Statin Use after Conversion to Mild Cognitive Impairment: Results in a Clinical Trial Cohort
D. Larry Sparks; Richard J. Kryscio; Donald J. Connor; Marwan N. Sabbagh; Lisa M. Sparks; Yushun Lin; Carolyn Liebsack
Neurodegener Dis (2010) 7 (1-3): 183–186.
https://doi.org/10.1159/000295660
Silencing/Overexpressing Selected Genes as a Model of Sporadic Parkinson’s Disease
Neurodegener Dis (2010) 7 (1-3): 108–111.
https://doi.org/10.1159/000285517
Generation of Tau Aggregates and Clearance by Autophagy in an Inducible Cell Model of Tauopathy
Neurodegener Dis (2010) 7 (1-3): 103–107.
https://doi.org/10.1159/000285516
p53 Is Regulated by and Regulates Members of the γ-Secretase Complex
Neurodegener Dis (2010) 7 (1-3): 50–55.
https://doi.org/10.1159/000283483
Are Aβ and Its Derivatives Causative Agents or Innocent Bystanders in AD?
Neurodegener Dis (2010) 7 (1-3): 32–37.
https://doi.org/10.1159/000266476
Subject Index Vol. 7, No. 1–3 2010
Neurodegener Dis (2010) 7 (1-3): 217–218.
https://doi.org/10.1159/000313307
Social Odor Recognition: A Novel Behavioral Model for Cognitive Dysfunction in Parkinson’s Disease
Michael M. Monaghan; Lauren Leddy; Mei-Li Amy Sung; Kristin Albinson; Katie Kubek; Menelas N. Pangalos; Peter H. Reinhart; Margaret M. Zaleska; Thomas A. Comery
Neurodegener Dis (2010) 7 (1-3): 153–159.
https://doi.org/10.1159/000289227
Human Analogue of the Morris Water Maze for Testing Subjects at Risk of Alzheimer’s Disease
Neurodegener Dis (2010) 7 (1-3): 148–152.
https://doi.org/10.1159/000289226
Transgenic Zebrafish as a Novel Animal Model to Study Tauopathies and Other Neurodegenerative Disorders in vivo
Neurodegener Dis (2010) 7 (1-3): 99–102.
https://doi.org/10.1159/000285515
Amyloid-β-Derived Diffusible Ligands Cause Impaired Axonal Transport of Mitochondria in Neurons
Neurodegener Dis (2010) 7 (1-3): 56–59.
https://doi.org/10.1159/000283484
History of Dementia Research in Bohemia and Middle Europe
Neurodegener Dis (2010) 7 (1-3): 6–9.
https://doi.org/10.1159/000283474
Lipid-Lowering Treatment Is Related to Decreased Risk of Dementia: A Population-Based Study (FINRISK)
Neurodegener Dis (2010) 7 (1-3): 180–182.
https://doi.org/10.1159/000295659
Leucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype Correlation
Neurodegener Dis (2010) 7 (1-3): 175–179.
https://doi.org/10.1159/000289232
Vascular Dementia and Alzheimer’s Disease – Are We in a Dead-End Road?
Margherita Cavalieri; Christian Enzinger; Katja Petrovic; Aga Pluta-Fuerst; Nina Homayoon; Helena Schmidt; Franz Fazekas; Reinhold Schmidt
Neurodegener Dis (2010) 7 (1-3): 122–126.
https://doi.org/10.1159/000285521
Acetylcholinesterase Variants in Alzheimer’s Disease: From Neuroprotection to Programmed Cell Death
Neurodegener Dis (2010) 7 (1-3): 60–63.
https://doi.org/10.1159/000285507
Transition of Tau Protein from Disordered to Misordered in Alzheimer’s Disease
Neurodegener Dis (2010) 7 (1-3): 24–27.
https://doi.org/10.1159/000283478
Vascular Contribution to Dementia in Parkinson’s Disease
Neurodegener Dis (2010) 7 (1-3): 127–130.
https://doi.org/10.1159/000285522
‘Prion-Like’ Propagation of Mouse and Human Tau Aggregates in an Inducible Mouse Model of Tauopathy
Neurodegener Dis (2010) 7 (1-3): 28–31.
https://doi.org/10.1159/000283479
Oophorectomy, Menopause, Estrogen, and Cognitive Aging: The Timing Hypothesis
Neurodegener Dis (2010) 7 (1-3): 163–166.
https://doi.org/10.1159/000289229
Cognitive Event-Related Potentials and Oscillations in the Subthalamic Nucleus
Neurodegener Dis (2010) 7 (1-3): 160–162.
https://doi.org/10.1159/000289228
The Vascular Hypothesis of Alzheimer’s Disease: Bench to Bedside and Beyond
Neurodegener Dis (2010) 7 (1-3): 116–121.
https://doi.org/10.1159/000285520
LRRK2 and the Stress Response: Interaction with MKKs and JNK-Interacting Proteins
Neurodegener Dis (2010) 7 (1-3): 68–75.
https://doi.org/10.1159/000285509
Possible Role of Tau in Mediating Pathological Effects of apoE4 in vivo prior to and following Activation of the Amyloid Cascade
Neurodegener Dis (2010) 7 (1-3): 16–23.
https://doi.org/10.1159/000283477
Common Variant in GRN Is a Genetic Risk Factor for Hippocampal Sclerosis in the Elderly
Neurodegener Dis (2010) 7 (1-3): 170–174.
https://doi.org/10.1159/000289231
Pharmacogenomic Protocols in CNS Disorders and Dementia
Neurodegener Dis (2010) 7 (1-3): 167–169.
https://doi.org/10.1159/000289230
Prevalence and Impact of Cerebrovascular Lesions in Alzheimer and Lewy Body Diseases
Neurodegener Dis (2010) 7 (1-3): 112–115.
https://doi.org/10.1159/000285518
Misframed Proteins and Neurodegeneration: A Novel View on Alzheimer’s and Parkinson’s Diseases
Neurodegener Dis (2010) 7 (1-3): 76–79.
https://doi.org/10.1159/000285510
Effects of Dopamine Agonists on Neuropsychiatric Symptoms of Parkinson’s Disease
Neurodegener Dis (2010) 7 (1-3): 206–209.
https://doi.org/10.1159/000295665
Filamentous Phages Reduce α-Synuclein Oligomerization in the Membrane Fraction of SH-SY5Y Cells
Neurodegener Dis (2010) 7 (1-3): 203–205.
https://doi.org/10.1159/000295664
Early Detection of Alzheimer’s Disease with PET Imaging
Neurodegener Dis (2010) 7 (1-3): 131–135.
https://doi.org/10.1159/000289222
Impaired Neurotransmitter Release in Alzheimer’s and Parkinson’s Diseases
Neurodegener Dis (2010) 7 (1-3): 80–83.
https://doi.org/10.1159/000285511
The Concept of Continuous Dopaminergic Stimulation: What We Should Consider when Starting Parkinson’s Disease Treatment
Neurodegener Dis (2010) 7 (1-3): 213–215.
https://doi.org/10.1159/000295667
Future Strategies for Neuroprotection in Parkinson’s Disease
Neurodegener Dis (2010) 7 (1-3): 210–212.
https://doi.org/10.1159/000295666
Inability of Plasma and Urine F2A-Isoprostane Levels to Differentiate Mild Cognitive Impairment from Alzheimer’s Disease
Neurodegener Dis (2010) 7 (1-3): 139–142.
https://doi.org/10.1159/000289224
Stem Cell Biology in the Study of Pathological Conditions
Neurodegener Dis (2010) 7 (1-3): 84–87.
https://doi.org/10.1159/000285512
Dissecting Toxicity of Tau and β-Amyloid
Neurodegener Dis (2010) 7 (1-3): 10–12.
https://doi.org/10.1159/000283475
Treatment of Alzheimer’s Disease with a Cholinesterase Inhibitor Combined with Antioxidants
Neurodegener Dis (2010) 7 (1-3): 193–202.
https://doi.org/10.1159/000295663
Retinoids as a Perspective in Treatment of Alzheimer’s Disease
Neurodegener Dis (2010) 7 (1-3): 190–192.
https://doi.org/10.1159/000295662
Increased CD44 Gene Expression in Lymphocytes Derived from Alzheimer Disease Patients
Neurodegener Dis (2010) 7 (1-3): 143–147.
https://doi.org/10.1159/000289225
Author Index Vol. 7, No. 1–3, 2010
Neurodegener Dis (2010) 7 (1-3): 216.
https://doi.org/10.1159/000313306
Title Page / Table of Contents
Neurodegener Dis (2010) 7 (1-3): 1–4.
https://doi.org/10.1159/000313305
Amyloid Imaging in Early Detection of Alzheimer’s Disease
Neurodegener Dis (2010) 7 (1-3): 136–138.
https://doi.org/10.1159/000289223
